Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Insights in tuberculosis immunology: Role of NKT and T regulatory cells.

Pandey P, Bhatnagar AK, Mohan A, Sachdeva KS, Vajpayee M, Das BK, Samantaray JC, Guleria R, Singh UB.

Int J Mycobacteriol. 2019 Oct-Dec;8(4):333-340. doi: 10.4103/ijmy.ijmy_141_19.

PMID:
31793502
2.

Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial.

Solomon SS, Quinn TC, Solomon S, McFall AM, Srikrishnan AK, Verma V, Kumar MS, Laeyendecker O, Celentano DD, Iqbal SH, Anand S, Vasudevan CK, Saravanan S, Thomas DL, Sachdeva KS, Lucas GM, Mehta SH.

J Hepatol. 2019 Oct 8. pii: S0168-8278(19)30588-4. doi: 10.1016/j.jhep.2019.09.022. [Epub ahead of print]

PMID:
31604081
3.

miR-511-3p protects against cockroach allergen-induced lung inflammation by antagonizing CCL2.

Do DC, Mu J, Ke X, Sachdeva K, Qin Z, Wan M, Ishmael FT, Gao P.

JCI Insight. 2019 Oct 17;4(20). pii: 126832. doi: 10.1172/jci.insight.126832.

4.

Tuberculosis (TB) intervention model targeting mobile population of truckers in Delhi, India.

Sharma N, Khanna A, Chandra S, Basu S, Bajaj D, Sachdeva KS, Ramachandran R.

Indian J Tuberc. 2019 Jul;66(3):382-387. doi: 10.1016/j.ijtb.2018.10.011. Epub 2018 Nov 8.

PMID:
31439184
5.

Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales data.

Arinaminpathy N, Batra D, Maheshwari N, Swaroop K, Sharma L, Sachdeva KS, Khaparde S, Rao R, Gupta D, Vadera B, Nair SA, Rade K, Kumta S, Dewan P.

BMC Infect Dis. 2019 Jun 19;19(1):539. doi: 10.1186/s12879-019-4169-y.

6.

What would it cost to scale-up private sector engagement efforts for tuberculosis care? Evidence from three pilot programs in India.

Deo S, Jindal P, Gupta D, Khaparde S, Rade K, Sachdeva KS, Vadera B, Shah D, Patel K, Dave P, Chopra R, Jha N, Papineni S, Vijayan S, Dewan P.

PLoS One. 2019 Jun 5;14(6):e0214928. doi: 10.1371/journal.pone.0214928. eCollection 2019.

7.
8.

Integrated HIV testing, prevention, and treatment intervention for key populations in India: a cluster-randomised trial.

Solomon SS, Solomon S, McFall AM, Srikrishnan AK, Anand S, Verma V, Vasudevan CK, Balakrishnan P, Ogburn EL, Moulton LH, Kumar MS, Sachdeva KS, Laeyendecker O, Celentano DD, Lucas GM, Mehta SH; Indian National Collaboration on AIDS Study.

Lancet HIV. 2019 May;6(5):e283-e296. doi: 10.1016/S2352-3018(19)30034-7. Epub 2019 Apr 2.

PMID:
30952565
9.

Assessing tuberculosis control priorities in high-burden settings: a modelling approach.

Vesga JF, Hallett TB, Reid MJA, Sachdeva KS, Rao R, Khaparde S, Dave P, Rade K, Kamene M, Omesa E, Masini E, Omale N, Onyango E, Owiti P, Karanja M, Kiplimo R, Alexandru S, Vilc V, Crudu V, Bivol S, Celan C, Arinaminpathy N.

Lancet Glob Health. 2019 May;7(5):e585-e595. doi: 10.1016/S2214-109X(19)30037-3. Epub 2019 Mar 20. Erratum in: Lancet Glob Health. 2019 Sep;7(9):e1179.

10.

Building a tuberculosis-free world: The Lancet Commission on tuberculosis.

Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, Chin DP, Churchyard G, Cox H, Ditiu L, Dybul M, Farrar J, Fauci AS, Fekadu E, Fujiwara PI, Hallett TB, Hanson CL, Harrington M, Herbert N, Hopewell PC, Ikeda C, Jamison DT, Khan AJ, Koek I, Krishnan N, Motsoaledi A, Pai M, Raviglione MC, Sharman A, Small PM, Swaminathan S, Temesgen Z, Vassall A, Venkatesan N, van Weezenbeek K, Yamey G, Agins BD, Alexandru S, Andrews JR, Beyeler N, Bivol S, Brigden G, Cattamanchi A, Cazabon D, Crudu V, Daftary A, Dewan P, Doepel LK, Eisinger RW, Fan V, Fewer S, Furin J, Goldhaber-Fiebert JD, Gomez GB, Graham SM, Gupta D, Kamene M, Khaparde S, Mailu EW, Masini EO, McHugh L, Mitchell E, Moon S, Osberg M, Pande T, Prince L, Rade K, Rao R, Remme M, Seddon JA, Selwyn C, Shete P, Sachdeva KS, Stallworthy G, Vesga JF, Vilc V, Goosby EP.

Lancet. 2019 Mar 30;393(10178):1331-1384. doi: 10.1016/S0140-6736(19)30024-8. Epub 2019 Mar 20. Review. No abstract available.

PMID:
30904263
11.

The end TB strategy for India.

Sachdeva KS, Mase SR.

Indian J Tuberc. 2019 Jan;66(1):165-166. doi: 10.1016/j.ijtb.2019.02.005. Epub 2019 Feb 27. Review.

PMID:
30878062
12.

Tuberculosis infection control measures at health care facilities offering HIV and tuberculosis services in India: A baseline assessment.

Sachdeva KS, Deshmukh RD, Seguy NS, Nair SA, Rewari BB, Ramchandran R, Parmar M, Vohra V, Singh S, Ghedia M, Agarwal R, Shah AN, Balasubramanian D, Bamrotiya M, Sikhamani R, Gupta RS, Khaparde SD.

Indian J Tuberc. 2018 Oct;65(4):280-284. doi: 10.1016/j.ijtb.2018.04.004. Epub 2018 Apr 19.

PMID:
30522613
13.

CBNAAT: A Boon for Early Diagnosis of Tuberculosis-Head and Neck.

Sachdeva K, Shrivastava T.

Indian J Otolaryngol Head Neck Surg. 2018 Dec;70(4):572-577. doi: 10.1007/s12070-018-1364-x. Epub 2018 Apr 16.

14.

Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India.

Moonan PK, Nair SA, Agarwal R, Chadha VK, Dewan PK, Gupta UD, Ho CS, Holtz TH, Kumar AM, Kumar N, Kumar P, Maloney SA, Mase SR, Oeltmann JE, Paramasivan CN, Parmar MM, Rade KK, Ramachandran R, Rao R, Salhorta VS, Sarin R, Sarin S, Sachdeva KS, Selvaraju S, Singla R, Surie D, Tonsing J, Tripathy SP, Khaparde SD.

BMJ Glob Health. 2018 Oct 8;3(5):e001135. doi: 10.1136/bmjgh-2018-001135. eCollection 2018.

15.

Developing a model to predict unfavourable treatment outcomes in patients with tuberculosis and human immunodeficiency virus co-infection in Delhi, India.

Madan C, Chopra KK, Satyanarayana S, Surie D, Chadha V, Sachdeva KS, Khanna A, Deshmukh R, Dutta L, Namdeo A, Shukla A, Sagili K, Chauhan LS.

PLoS One. 2018 Oct 3;13(10):e0204982. doi: 10.1371/journal.pone.0204982. eCollection 2018.

16.

Low Gonadotropin Dosage Reduces Aneuploidy in Human Preimplantation Embryos: First Clinical Study in a UAE Population.

Sachdeva K, Upadhyay D, Discutido R, Varghese MM, Albuz F, Almekosh R, Bouhafs L, Solkar S, Stevikova M, Peramo B.

Genet Test Mol Biomarkers. 2018 Oct;22(10):630-634. doi: 10.1089/gtmb.2018.0063. Epub 2018 Sep 7.

PMID:
30199281
17.

Use of Computer-Assisted Personal Interviewing and Information Management System in a Survey among HIV High-Risk Groups in India: Strengths, Weaknesses, Opportunities, and Threats Analysis.

Brahme R, Godbole S, Gangakhedkar R, Sachdeva KS, Verma V, Risbud A.

Indian J Community Med. 2018 Apr-Jun;43(2):107-112. doi: 10.4103/ijcm.IJCM_273_17.

18.

Health risk assessment due to biomass smoke exposure in Indian indoor environment: An empirical approach using lung deposition model.

Tigala S, Sharma AR, Sachdeva K.

Sci Total Environ. 2018 Nov 1;640-641:935-942. doi: 10.1016/j.scitotenv.2018.05.323. Epub 2018 Jun 5.

PMID:
29879675
19.
20.

Social support a key factor for adherence to multidrug-resistant tuberculosis treatment.

Deshmukh RD, Dhande DJ, Sachdeva KS, Sreenivas AN, Kumar AMV, Parmar M.

Indian J Tuberc. 2018 Jan;65(1):41-47. doi: 10.1016/j.ijtb.2017.05.003. Epub 2017 Jun 2.

PMID:
29332647
21.

Mutilating Lesions of Face.

Sachdeva K, Upadhyay A.

Indian J Otolaryngol Head Neck Surg. 2017 Dec;69(4):527-534. doi: 10.1007/s12070-017-1203-5. Epub 2017 Sep 9.

22.

Nations within a nation: variations in epidemiological transition across the states of India, 1990-2016 in the Global Burden of Disease Study.

India State-Level Disease Burden Initiative Collaborators.

Lancet. 2017 Dec 2;390(10111):2437-2460. doi: 10.1016/S0140-6736(17)32804-0. Epub 2017 Nov 14. Erratum in: Lancet. 2017 Dec 2;390(10111):e49.

23.

Demarcation line depth after contact lens-assisted corneal crosslinking for progressive keratoconus: Comparison of dextran-based and hydroxypropyl methylcellulose-based riboflavin solutions.

Malhotra C, Jain AK, Gupta A, Ram J, Ramatchandirane B, Dhingra D, Sachdeva K, Kumar A.

J Cataract Refract Surg. 2017 Oct;43(10):1263-1270. doi: 10.1016/j.jcrs.2017.07.032.

PMID:
29120712
24.

Capturing forest dependency in the central Himalayan region: Variations between Oak (Quercus spp.) and Pine (Pinus spp.) dominated forest landscapes.

Chakraborty A, Joshi PK, Sachdeva K.

Ambio. 2018 May;47(4):504-522. doi: 10.1007/s13280-017-0947-1. Epub 2017 Oct 5.

25.

Meso level multi-disciplinary approach for reduction of pre-treatment loss to follow-up in Revised National Tuberculosis Control Program, Delhi, India.

Sharma N, Chandra S, Dhuria M, Kohli C, Chopra KK, Aggarwal N, Sachdeva K.

Indian J Tuberc. 2017 Oct;64(4):281-290. doi: 10.1016/j.ijtb.2017.05.010. Epub 2017 Jun 13.

PMID:
28941850
26.

Validation of Next-Generation Sequencer for 24-Chromosome Aneuploidy Screening in Human Embryos.

Sachdeva K, Discutido R, Albuz F, Almekosh R, Peramo B.

Genet Test Mol Biomarkers. 2017 Nov;21(11):674-680. doi: 10.1089/gtmb.2017.0108. Epub 2017 Sep 8.

PMID:
28885040
27.

Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis.

Khaparde S, Raizada N, Nair SA, Denkinger C, Sachdeva KS, Paramasivan CN, Salhotra VS, Vassall A, Hoog AV.

PLoS One. 2017 Sep 7;12(9):e0184270. doi: 10.1371/journal.pone.0184270. eCollection 2017.

28.

Index-TB guidelines: Guidelines on extrapulmonary tuberculosis for India.

Sharma SK, Ryan H, Khaparde S, Sachdeva KS, Singh AD, Mohan A, Sarin R, Paramasivan CN, Kumar P, Nischal N, Khatiwada S, Garner P, Tharyan P.

Indian J Med Res. 2017 Apr;145(4):448-463. doi: 10.4103/ijmr.IJMR_1950_16.

29.

Outcomes of Newborn Hearing Screening Program: A Hospital Based Study.

Sachdeva K, Sao T.

Indian J Otolaryngol Head Neck Surg. 2017 Jun;69(2):194-198. doi: 10.1007/s12070-017-1062-0. Epub 2017 Jan 17.

30.

Bottom-up or top-down: unit cost estimation of tuberculosis diagnostic tests in India.

Rupert S, Vassall A, Raizada N, Khaparde SD, Boehme C, Salhotra VS, Sachdeva KS, Nair SA, Hoog AH.

Int J Tuberc Lung Dis. 2017 Apr 1;21(4):375-380. doi: 10.5588/ijtld.16.0496.

31.

Correlation of Radiological and Endoscopic Findings in Patients Presenting with Dysphagia.

Sachdeva K, Kaul V.

Indian J Otolaryngol Head Neck Surg. 2017 Mar;69(1):72-76. doi: 10.1007/s12070-016-1047-4. Epub 2017 Jan 9.

32.

Neck Trauma: ENT Prospects.

Sachdeva K, Upadhyay A.

Indian J Otolaryngol Head Neck Surg. 2017 Mar;69(1):52-57. doi: 10.1007/s12070-016-1048-3. Epub 2017 Jan 4.

33.

Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis.

Velayutham B, Nair D, Kannan T, Padmapriyadarsini C, Sachdeva KS, Bency J, Klinton JS, Haldar S, Khanna A, Jayasankar S, Swaminathan S.

Int J Tuberc Lung Dis. 2016 Dec;20(12):1671-1676.

PMID:
27931345
34.

Innovatively addressing the challenge of maintaining binocular microscopes under Tuberculosis Programme in India - Is this feasible?

Chadha S, Nagaraja SB, Prasad BM, Kelamane S, Satyanarayana S, Sachdeva KS.

Indian J Tuberc. 2016 Jan;63(1):48-50. doi: 10.1016/j.ijtb.2016.02.004. Epub 2016 Apr 29.

PMID:
27235945
35.

Scaling up of HIV-TB collaborative activities: Achievements and challenges in India.

Deshmukh R, Shah A, Sachdeva KS, Sreenivas AN, Gupta RS, Khaparde SD.

Indian J Tuberc. 2016 Jan;63(1):4-7. doi: 10.1016/j.ijtb.2016.02.003. Epub 2016 Apr 29.

PMID:
27235937
36.

Myxoid Chondrosarcoma of Nasomaxilloethmoid Region with Intracranial Extension.

Sachdeva K, Sachdeva N.

Indian J Otolaryngol Head Neck Surg. 2016 Mar;68(1):110-4. doi: 10.1007/s12070-015-0944-2. Epub 2016 Jan 29.

37.

Experience of active tuberculosis case finding in nearly 5 million households in India.

Prasad BM, Satyanarayana S, Chadha SS, Das A, Thapa B, Mohanty S, Pandurangan S, Babu ER, Tonsing J, Sachdeva KS.

Public Health Action. 2016 Mar 21;6(1):15-8. doi: 10.5588/pha.15.0035. Epub 2016 Jan 25.

38.

Transitioning to daily treatment for drug-sensitive TB in India.

Sachdeva KS, Shah A, Rade K, Ramachandran R, Sreenivas A, Parmar M, Ghedia M, Salhotra VS, Khaprde SD, Prasad J.

Indian J Tuberc. 2015 Oct;62(4):239-42. doi: 10.1016/j.ijtb.2015.11.005. Epub 2016 Jan 27.

PMID:
26970467
39.

Airborne infection control in India: Baseline assessment of health facilities.

Parmar MM, Sachdeva KS, Rade K, Ghedia M, Bansal A, Nagaraja SB, Willis MD, Misquitta DP, Nair SA, Moonan PK, Dewan PK.

Indian J Tuberc. 2015 Oct;62(4):211-7. doi: 10.1016/j.ijtb.2015.11.006. Epub 2016 Jan 23.

40.

Standards for TB care in India: A tool for universal access to TB care.

Nair SA, Sachdeva KS, Malik P, Chandra S, Ramachandran R, Kulshrestha N, Chopra KK, Khaparde SD.

Indian J Tuberc. 2015 Oct;62(4):200-6. doi: 10.1016/j.ijtb.2015.11.004. Epub 2016 Jan 23. Review.

PMID:
26970459
41.

Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis.

Nair SA, Raizada N, Sachdeva KS, Denkinger C, Schumacher S, Dewan P, Kulsange S, Boehme C, Paramsivan CN, Arinaminpathy N.

PLoS One. 2016 Feb 26;11(2):e0150054. doi: 10.1371/journal.pone.0150054. eCollection 2016.

42.

Genotypic, Phenotypic and Clinical Validation of GeneXpert in Extra-Pulmonary and Pulmonary Tuberculosis in India.

Singh UB, Pandey P, Mehta G, Bhatnagar AK, Mohan A, Goyal V, Ahuja V, Ramachandran R, Sachdeva KS, Samantaray JC.

PLoS One. 2016 Feb 19;11(2):e0149258. doi: 10.1371/journal.pone.0149258. eCollection 2016.

43.

Direct Observation of Treatment Provided by a Family Member as Compared to Non-Family Member among Children with New Tuberculosis: A Pragmatic, Non-Inferiority, Cluster-Randomized Trial in Gujarat, India.

Dave PV, Shah AN, Nimavat PB, Modi BB, Pujara KR, Patel P, Mehariya K, Rade KV, Shekar S, Sachdeva KS, Oeltmann JE, Kumar AM.

PLoS One. 2016 Feb 5;11(2):e0148488. doi: 10.1371/journal.pone.0148488. eCollection 2016.

44.

Treatment of childhood tuberculosis in India.

Swaminathan S, Sachdeva KS.

Int J Tuberc Lung Dis. 2015 Dec;19 Suppl 1:43-46. doi: 10.5588/ijtld.15.0611.

PMID:
26564540
45.

Piloting Upfront Xpert MTB/RIF Testing on Various Specimens under Programmatic Conditions for Diagnosis of TB & DR-TB in Paediatric Population.

Raizada N, Sachdeva KS, Swaminathan S, Kulsange S, Khaparde SD, Nair SA, Khanna A, Chopra KK, Hanif M, Sethi GR, Umadevi KR, Keshav Chander G, Saha B, Shah A, Parmar M, Ghediya M, Jaju J, Boehme C, Paramasivan CN.

PLoS One. 2015 Oct 15;10(10):e0140375. doi: 10.1371/journal.pone.0140375. eCollection 2015.

46.

Follow-up examinations: are multidrug-resistant tuberculosis patients in Uttar Pradesh, India, on track?

Tripathi UC, Nagaraja SB, Tripathy JP, Sahu SK, Parmar M, Rade K, Bhatnagar S, Ranjan A, Sachdeva KS.

Public Health Action. 2015 Mar 21;5(1):59-64. doi: 10.5588/pha.14.0095.

47.

Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in India.

Deshmukh RD, Dhande DJ, Sachdeva KS, Sreenivas A, Kumar AM, Satyanarayana S, Parmar M, Moonan PK, Lo TQ.

PLoS One. 2015 Aug 24;10(8):e0135802. doi: 10.1371/journal.pone.0135802. eCollection 2015.

48.

The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis.

Sachdeva KS, Raizada N, Gupta RS, Nair SA, Denkinger C, Paramasivan CN, Kulsange S, Thakur R, Dewan P, Boehme C, Arinaminpathy N.

PLoS One. 2015 Jul 1;10(7):e0131438. doi: 10.1371/journal.pone.0131438. eCollection 2015.

49.

Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.

Sachdeva KS, Raizada N, Sreenivas A, Van't Hoog AH, van den Hof S, Dewan PK, Thakur R, Gupta RS, Kulsange S, Vadera B, Babre A, Gray C, Parmar M, Ghedia M, Ramachandran R, Alavadi U, Arinaminpathy N, Denkinger C, Boehme C, Paramasivan CN.

PLoS One. 2015 May 21;10(5):e0126065. doi: 10.1371/journal.pone.0126065. eCollection 2015.

50.

Challenges in tuberculosis diagnosis and management: recommendations of the expert panel.

Singh S, Dey B, Sachdeva KS, Kabra SK, Chopra KK, Chaudhary VK, Sharma P, Katoch VM.

J Lab Physicians. 2015 Jan-Jun;7(1):1-3. doi: 10.4103/0974-2727.154778. No abstract available.

Supplemental Content

Loading ...
Support Center